2963-69-1 ((3beta,7alpha,15alpha)-3,7,15-三羟基雄甾-5-烯-17-酮,3b,7a,15a-Trihydroxyandrost-5-en-17-one)

(3beta,7alpha,15alpha)-3,7,15-三羟基雄甾-5-烯-17-酮;7a 15a-二羟基雄甾酮;三羟物;鑫源顺 (3beta,7alpha,15alpha)-3,7,15-三羟基雄甾-5-烯-17-酮;

3b,7a,15a-Trihydroxyandrost-5-en-17-one;Androst-5-en-17-one, 3,7,15-trihydroxy-, (3beta,7alpha,15alpha)- (9CI);2963-69-1;(3beta,7alpha,15alpha)-3,7,15-Trihydroxy-androst-5-en-17-one;DTXSID701036209;SCHEMBL855786;(3S,7S,8R,9S,10R,13S,14S,15S)-3,7,15-trihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one;Androst-5-en-17-one, 3,7,15-trihydroxy-, (3beta,7alpha,15alpha)-;3beta,7alpha,15alpha-trihydroxy-5-androsten-17-one;(3S, 7S, 8R, 9S, 10R, 13S, 14S, 15S)-3, 7, 15-trihydroxy-10, 13-dimethyl-1, 2, 3, 4, 7, 8, 9, 11, 12, 14, 15, 16-dodecahydrocyclopenta[a]phenanthren-17-one;NS00011526;

MFCD11617959

FTEHGIIZAGEILF-NSSDSGNWSA-N

1S/C19H28O4/c1-18-5-3-11(20)7-10(18)8-13(21)16-12(18)4-6-19(2)15(23)9-14(22)17(16)19/h8,11-14,16-17,20-22H,3-7,9H2,1-2H3/t11-,12-,13+,14-,16-,17-,18-,19+/m0/s1

O[C@H]1CC([C@@]2(C)CC[C@@H]3[C@@]4(C)CC[C@@H](CC4=C[C@H]([C@H]3[C@@H]21)O)O)=O